Evidence map›Paper›PMID 40709419›Full record

ReviewThe Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi2025

Risk of Pancreatic Cancer in Inflammatory Pancreatic Diseases.

J-Matthias Löhr, Miroslav Vujasinovic, Patrick Maisonneuve

Abstract readReview
In one paragraph

Review in The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

J-Matthias LöhrKarolinska Institutet & Karolinska Comprehensive Cancer Center, Stockholm, Sweden.ORCID 0000-0002-7647-198X
Miroslav VujasinovicKarolinska Institutet & Karolinska Comprehensive Cancer Center, Stockholm, Sweden.
Patrick MaisonneuveDivision of Epidemiology & Biostatistics, IEO European Institute of Oncology, IRCSS, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

All known inflammatory diseases of the pancreas, i.e., acute, chronic, hereditary, and autoimmune pancreatitis, carry a higher risk of developing pancreatic cancer. The risk is highest in hereditary and chronic pancreatitis and lowest in acute and autoimmune pancreatitis. Although established risk factors such as smoking have been known for decades, obesity, diabetes mellitus, and pancreatic exocrine insufficiency have emerged. In addition, the microbiome/use of antibiotics and microplastic are novel risk factors for the development of pancreatic cancer that have not been explored.

Indexed as

PancreasPancreatic NeoplasmsPancreatitisHumansRisk FactorsAcute pancreatitisAutoimmune pancreatitisChronic pancreatitisHereditary pancreatitisPancreatic cancer

Identifiers

PMID40709419
PMCPMC12305077

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.